Rapid detection of all HLA-B*27 alleles (B*2701-B*2725) by group-specific polymerase chain reaction

Tissue Antigens

Volumn 63, Issue 1, 2004, Pages 88-92

  Zino, E ^a,b   Di Terlizzi, S ^a,b   Carugo, C ^a   Baggi, L ^a   Galli, A ^a   Bonini, C ^a   Rossini, S ^a   Mazzi, B ^a   Fleischhauer, K ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Diagnosis of rheumatic diseases; Group specific detection; HLA B*27; Sequence specific primer

Indexed keywords

HLA B ANTIGEN;

ALLELE; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE SEQUENCE; HUMAN; METHODOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCREENING;

ALLELES; BASE SEQUENCE; DNA PRIMERS; GENE FREQUENCY; HISTOCOMPATIBILITY TESTING; HLA-B27 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 1642439865     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2004.00158.x     Document Type: Article

References (13)

1. Granfors K, Marker-Hermann E, de Keyser F, Khan MA, Veys EM, Yu DT. The cutting edge of spondylarthropathy research in the millennium. Arthritis Rheum 2002: 46: 606-13.
2. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 2001: 13: 265-72.
3. Coates E, Darke C. Routine HLA-B27 typing by flow cytometry: differentiation of the products of HLA-B*2702, B*2705 and B*2708. Eur J Immunogenet 1998: 25: 29-37.
4. Kirveskari J, Kellner H, Wuorela M et al. False-negative serological HLA-B27 typing results may be due to altered antigenic epitopes and can be detected by polymerase chain reaction. Br J Rheumatol 1997: 36: 185-9.
5. Marsh SG, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system. Hum Immunol 2002: 63: 1213-68.
6. Olerup O. HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens 1994: 43: 253-6.
7. Wagner T, Oberkanins C, Weinmayr B, Helmberg W, Kury F, Lanzer G. HLA-B*27 typing by group-specific hybridization in microtiter plates. Tissue Antigens 1998: 52: 175-8.
8. Voorter CE, Swelsen WT, van den Berg-Loonen EM. B*27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens 2002: 60: 25-35.
9. Weynants P, Lethe B, Brasseur F, Marchand M, Boon T. Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer 1994: 56: 826-9.
10. Kimura A, Sasazuki T. Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique. In: Tsuyi KI, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Hisocompatibility Workshop and Conference. Oxford University Press, Oxford, UK 1991: 397-419.
11. Ando H, Mizuki N, Ohno S et al. Identification of a novel HLA-B allele (B*4202) in a Saudi Arabian family with Behcet's disease. Tissue Antigens 1997: 49: 526-8.
12. Clavijo OP, Delgado JC, Yu N, Fraser PA, Yunis EJ. HLA-Cw*1701 is associated with two sub-Saharan African-derived HLA haplotypes: HLA-B*4201, DRB1*03 and HLA-B*4202 without DRB1*03. Tissue Antigens 1999: 54: 303-6.
13. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population: the national marrow donor program donor registry. Transplantation 1997: 64: 1017-27.